Instruction for use: DriptaneI want this, give me price
Active substance: Oxybutynin
Antispasmodics [Spazmolitiki myotropic]
The nosological classification (ICD-10)
N31 Neuromuscular dysfunction of bladder, not elsewhere classified
Overactive bladder syndrome, Idiopathic violation of detrusor function, detrusor dysfunction, Spasmodic neurogenic bladder dysfunction
R32 Urinary incontinence unspecified
daytime enuresis, Idiopathic bladder instability, Urinary incontinence, nocturia, The disorder of the bladder sphincter function, Spontaneous urination, Mixed forms of urinary incontinence, Functional disorders of micturition, Functional micturition disorders, Functional enuresis in children, Enuresis
Structure and Composition
Tablets 1 tab.
5 mg of oxybutynin hydrochloride
Other ingredients: MCC; calcium stearate; lactose anhydrous
in blister 30 pcs .; In the paper cartons 1 blister.
The drug forms
Tablets of white color, round, biconcave, with Valium on one party.
Mode of action - antispasmodic, myotropic.
It relaxes the detrusor (muscle that reduces the bladder). It provides direct antispasmodic myotropic and m-anticholinergic action. Increases the capacity of the bladder, reduces the incidence of detrusor contractions, holding back the urge to urinate.
Cmax after oral administration is achieved after 45 minutes. The concentration is proportional to the applied dose. T1 / 2 is less than 2 hours (increases in elderly patients).
urinary incontinence associated with bladder instability function, impaired either by nature neurogenic disorders (detrusor hyperreflexia), such as disseminated sclerosis or spina bifida, or in idiopathic detrusor function disorders (incontinence engine);
nocturnal enuresis in children older than 5 years.
Hypersensitivity to the drug;
obstruction of the gastrointestinal tract, intestinal, expansion of the colon, ulcerative colitis;
Children up to age 5 years.
Pregnancy and breast-feeding
During pregnancy DriptaneŽ apply only under strict conditions. If necessary, use during lactation should decide the issue of termination of breastfeeding.
Nausea, constipation, diarrhea, discomfort in the abdomen, urinary retention, drowsiness or insomnia, weakness, headache, dizziness, arrhythmia, impaired vision (mydriasis, paralysis of accommodation), increased intraocular pressure, decreased sweating, dry mouth, impotence, allergic reactions.
Dosing and Administration
Inside. Adults - 5 mg 2-3 times per day, children and elderly patients - 5 mg 2 times a day.
Symptoms: CNS arousal (anxiety, tremors, increased nervous irritability, convulsions, delirium, hallucinations), fever, nausea, vomiting, tachycardia, decreased blood pressure, respiratory failure, paralysis, coma.
Treatment: should maintain breathing, vomit or to gastric lavage, activated charcoal, and assign a saline laxative. For regression anticholinergic symptoms of intoxication using cholinesterase blockers (physostigmine). In marked anxiety or excitation - in / in a 10 mg diazepam. When tachycardia - propranolol (w / w).
Caution is needed when kidney function and liver, hyperthyroidism, coronary artery disease, heart failure, arrhythmias, hypertension, prostate cancer, hiatal hernia.
The temperature is not above 30 ° C.
Keep out of the reach of children.
Do not use beyond the expiration date printed on the package.